Concurrent Systems Revenue and Competitors

Newbury, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Concurrent Systems's estimated annual revenue is currently $1.4M per year.(i)
  • Concurrent Systems's estimated revenue per employee is $87,000

Employee Data

  • Concurrent Systems has 16 Employees.(i)

Concurrent Systems's People

NameTitleEmail/Phone
1
CEO and PLM ConsultantReveal Email/Phone
2
Development DirectorReveal Email/Phone
3
Technical DirectorReveal Email/Phone
4
Operations ManagerReveal Email/Phone
5
Quality Assurance - DDM PLMReveal Email/Phone
6
Marketing ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.5M7N/AN/AN/A
#2
$3720M135810%$26.5M$1.2B
#3
$34.9M219N/AN/AN/A
#4
$22.6M1455%$18.2MN/A
#5
$32.9M206-2%N/AN/A
#6
$72.5M400N/AN/AN/A
#7
$2M28-50%$7.5MN/A
#8
$46.3M2970%$142MN/A
#9
$15.4M1064%N/AN/A
#10
$13.3M92N/AN/AN/A
#11
$5.3M46N/AN/AN/A
#12
$148M7140%$138.2MN/A
#13
$37.2M93N/AN/AN/A
#14
$12M55N/AN/AN/A
#15
$40.5M254N/AN/AN/A
#16
$2.8M28N/AN/AN/A
#17
$170.5M840N/AN/AN/A
#18
$382.2M1241N/AN/AN/A
#19
$0.6M8N/AN/AN/A
#20
$4.2M38-32%$21.4MN/A
Add Company

What Is Concurrent Systems?

keywords:N/A

N/A

Total Funding

16

Number of Employees

$1.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Concurrent Systems News

2022-04-20 - Qvella FAST System and FAST-PBC Prep Cartridge Get CE ...

Qvella FAST System and FAST-PBC Prep Cartridge Get CE Marked and FDA Listed for In Vitro Diagnostic Use · Qvella · Concurrent with the marketing...

2022-04-20 - Qvella Obtains CE Mark, FDA Listing for Blood Culture ...

The system and prep cartridge are fully automated technologies to ... Concurrent with the marketing authorization and commercialization of...

2022-04-20 - VOLUNTEER, DESIGN, BUILD

Designing was concurrent with constructing, systems were tried out along the project, details were sketched at site and materials were...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M1678%N/A
#2
$2.1M19-14%N/A
#3
$2.1M21-22%N/A
#4
$5.8M23-15%N/A
#5
$3.1M2567%N/A